Carol Friedman, D.O. Associate Director for Adult Immunization Immunization Services Division National Center for Immunization and Respiratory Diseases.

Slides:

Advertisements

Similar presentations

DSHS Immunization Activities to Raise Texas Vaccine Coverage Levels Jack Sims, Manager Immunization Branch September 19, 2006.

Advertisements

Influenza Vaccine Manufacturing

INFLUENZA DIVISION U.S. Influenza Surveillance Update, Season Joseph Bresee, MD Epidemiology and Prevention Branch, Influenza Division, CDC VRBPAC.

Vaccines and Related Biological Products Advisory Committee 18 February 2009 Topic 2: Considerations and Implications for adding two B Strains to the Seasonal.

Tonya Philbrick, BS, NCMA Director

SISD School Nurses are following DSHS and CDC guidelines in sending these type of students home……. Send sick students, teachers, and staff home and advise.

INSTRUCTIONS These slides are templates to use for educational purposes for your facility’s campaign to immunize healthcare personnel against influenza.

Lisa Grohskopf, MD, MPH Medical Officer Influenza Division Centers for Disease Control and Prevention U.S. Influenza Surveillance National Center for Immunization.

U.S. Surveillance Update Anthony Fiore, MD, MPH CAPT, USPHS Influenza Division National Center for Immunizations and Respiratory Disease Centers for Disease.

Global Vaccines 202X : Access, Equity, Ethics Panel discussion: Pandemic Influenza Preparedness Framework for the sharing of Influenza Viruses and Access.

Office for Oregon Health Policy & Research Oregon Healthcare Worker Influenza Vaccination Rates Jeanne Negley, MBA Elyssa Tran, MPA August 2011.

Adult Immunization 2010 Influenza Segment This material is in the public domain This information is valid as of May 25, 2010.

Influenza Vaccine Manufacturing Industry perspective for influenza vaccine supply VRBPAC, 27 February 2013 The FDA CBER requested this annual.

Influenza Virus Vaccine Strain Selection Vaccines and Related Biological Products Advisory Committee (2/28/2014) Jerry P. Weir, Ph.D., Director.

How Public Health Centers in Suffolk County, NY Strove to Leave No Vaccine Behind Mary Beth Koslap-Petraco, MS, CPNP Brian L. Harper, MD, MPH Suffolk County.

Influenza Virus Vaccine Strain Selection Vaccines and Related Biological Products Advisory Committee (2/25/2011) Jerry P. Weir, Ph.D., Director.

MEASLES VACCINATION 2015 Update Susan Reeser RN, BSN (406)

Seasonal Influenza Vaccination: Looking Ahead Toward the Season Jeanne M. Santoli Immunization Services Division National Center.

Seasonal Influenza Vaccine Update Jeanne M. Santoli, MD, MPH National Center for Immunization and Respiratory Diseases Centers for Disease Control and.

Immunization in the Time of H1N1 Anne Schuchat, MD Rear Admiral, US Public Health Service Director, National Center for Immunization and Respiratory Diseases.

Title page Influenza and Older Adults COM R.

VRBPAC 25 February 2011 Influenza Vaccine Manufacturing Industry Perspective for Vaccine Supply.

WATER FOR THE FUTURE – WILL WE ACCEPT THE CHALLENGE OR WILL WE POSTPONE IT ? WILL YOU BE PART OF THE ANSWER ? ( or will others use your resources to solve.

THE NATIONAL INFLUENZA VACCINE SUMMIT: UPDATE Raymond A. Strikas, M.D. Immunization Services Division National Immunization Program Coordinating Center.

State Affiliate Challenge 1 South Dakota School Nurses Association Florida Association of School Nurses Delaware School Nurse Association.

Influenza Update September 2015

Vaccines for Children Program Stockpile Status National Vaccine Advisory Committee February 4, 2010 Washington, DC Lance E Rodewald, MD Director, Immunization.

American Academy of Pediatrics, Committee on Infectious Diseases. Policy Statement—Recommendations for Prevention and Control of Influenza in Children,

State Health Officer Webcast, February 27, 2015 Wisconsin Division of Public Health Wisconsin Department of Health Services Thomas Haupt Influenza Surveillance.

Office of Public Health Preparedness and Response Division of Strategic National Stockpile Ben Erickson Public Health Analyst Inventory Management Tracking,

Food and Drug Administration

Texas Immunization Branch Influenza Update July 24 th, 2008.

Influenza Vaccine Supply : Issues and Opportunities Raymond A. Strikas, M.D. National Immunization Program Coordinating Center for Infectious Diseases.

A Potential Influenza Pandemic: Possible Macroeconomic Effects and Policy Issues Julie Somers Congressional Budget Office Prepared for the Ninth Annual.

H1N1 Virus (Swine Flu) By: Emalee Ramirez & Ashley Towe.

Influenza Vaccination Update for Jeanne M. Santoli, MD, MPH Deputy Director, Immunization Services Division National Center for Immunization and.

VACCINES AND RELATED BIOLOGICAL PRODUCTS ADVISORY COMMITTEE USPHS INFLUENZA VIRUS VACCINE STRAIN SELECTION

Introduction for Basic Epidemiological Analysis for Surveillance Data National Center for Immunization & Respiratory Diseases Influenza Division.

Agree Disagree 1._______ ________ 2._______ ________ 3._______ ________ 5._______ ________ 4._______ ________ An epidemic is worse than a pandemic. The.

TM OPV Stockpiling in the United States Trudy V. Murphy, M.D. National Immunization Program Centers for Disease Control and Prevention February 5, 2003.

Planning for the Influenza Season: Will it be Rain, Shine, or Hurricane? National Vaccine Advisory Committee June 7, 2005 Washington, DC Raymond.

National Vaccine Advisory Committee Report from the Chair Gus Birkhead, MD, MPH NVAC Chair February 3, 2010.

The Influenza Immunization Season: An Early Look at Communications and Media Planning Glen Nowak, Ph.D. Director, Media Relations Centers for Disease.

A Vaccine Supply Update For The U.S. Market A Presentation At The National Vaccine Advisory Committee Meeting June 3, 2003 Dean Mason Chief, Program Support.

INFLUENZA UPDATE DEBBYE ROSEN ADULT IMMUNIZATION COORDINATOR CONNECTICUT DEPARTMENT OF PUBLIC HEALTH

Influenza A (H1N1) Vaccine Vaccines and Related Biological Products Advisory Committee Meeting, 23 July 2009 Raburn Mallory, M.D. Proprietary Vaccines.

Vaccines and Related Biological Products Advisory Committee Meeting July 23, 2009 Novel influenza A (H1N1) Epidemiology Update Anthony Fiore, MD, MPH Influenza.

INFLUENZA LUKE UYEMURA ENGLISH 100 ESP. BASIC INFO Definition: Influenza, more commonly know as the flu, is a viral infection that attacks your respiratory.

FDA’s Role in Facilitating the Availability of Influenza Vaccine Norman W. Baylor, Ph.D. Director, Office of Vaccines Research and Review CBER/FDA.

A Vaccine Supply Update For The U.S. Market A Presentation At National Advisory Committee Meeting February 4, 2003 Dean Mason Chief, Program Support Branch.

OVERVIEW OF THE NATIONAL INFLUENZA VACCINE SUMMIT Dennis J. O’Mara Associate Director for Adult Immunization Immunization Services Division National Immunization.

Plans to Assess the Effectiveness of Seasonal and Pandemic Influenza Vaccines during David Shay MD, MPH (Prevention Assessment and Modeling Team.

2015 Connecticut Influenza Update Mick Bolduc Connecticut Immunization Program December 15,

Planning for the Influenza Season National Vaccine Advisory Committee February 8, 2005 Washington, DC Lance E. Rodewald, MD Director, Immunization.

Update from the 2010 National Influenza Vaccine Summit meeting L.J Tan Co-chair, National Influenza Vaccine Summit Director, Medicine and Public Health,

Non-institutionalized adults vaccinated annually against influenza and ever vaccinated against pneumococcal disease. Healthy Kansans 2010 Steering Committee.

Lisa Grohskopf, MD, MPH U.S. Influenza Surveillance Season National Center for Immunization & Respiratory Diseases Influenza Division U.S. Food.

INFLUENZA AND INFECTIOUS DISEASE FORUM JULY 29, 2010 ERIN BACHUS, ADULT IMMUNIZATION COORDINATOR COMMUNICABLE DISEASE CONTROL AND PREVENTION SAN FRANCISCO.

ACIP Recommendations Update for the U.S. Influenza Season

Vaccination Rates in Idaho: Updates Fall 2017

Amy Groom, MPH IHS Immunization Program Manager/CDC Field Assignee

Recommended Timeline for Influenza Vaccinations

Influenza Vaccine Distribution

Adult Immunization: Making the Most of Everyday Opportunities

Immunizing the Older Adult: Challenges and Opportunities

ACIP Recommended Vaccines for Adults – By Age

Peng-jun Lu, MD, PhD1; Mei-Chun Hung, MPH, PhD1,2 ; Alissa C

Healthy People 2010 Focus Area 14

Influenza Experience: Highlights and Comments

WHAT IF THE VACCINE IS NOT A GOOD MATCH?

Presentation transcript:

Carol Friedman, D.O. Associate Director for Adult Immunization Immunization Services Division National Center for Immunization and Respiratory Diseases Centers for Disease Control and Prevention Seasonal Flu Vaccine Update

Seasonal Flu Vaccine Supply June 2009 vaccine manufacturers state 118 million doses of seasonal flu vaccine will be produced August 2009 numbers revised to 114 million doses produced Represents ~3% reduction from original projection Amount of vaccine distributed similar to flu season

U.S. Seasonal Influenza Vaccine: Production and Use Doses Produced (millions) Doses Distributed (millions) (est)112.7* *Amount reported by manufacturers to CDC which is being validated.

Vaccine Supply Challenges Vaccine available much earlier Increased demand Facilities switched to production of H1N1 vaccine production Delay in availability of vaccine Pre-booked orders canceled or reduced

Long-Term Care Facilities (LTCF) Affected Reports of vaccine shortages among LTCFs –Orders canceled or reduced Additional 500,000 doses made available for LTCF in December Pharmacies, supermarkets, community vaccinators provided vaccine

Demand Remains High Cumulative seasonal influenza vaccination coverage since August was 42% by Jan 2 Demand for seasonal vaccine remains higher than supply ( million vs. 114 available) –Majority of people report they have gotten, will definitely get, or will probably get seasonal flu vaccine (58%)

Outlook for Next Season ACIP Influenza Work Group considering universal flu recommendation –Begin –Two stage Encourage for Full implementation Fluzone High Dose Vaccine –High-dose seasonal flu vaccine for persons ≥65 years –Contains 4 x amount of antigen –FDA licensed December

Outlook for Next Season (2) Preliminary reports indicate manufacturers plan to make at least as much vaccine as this year –Will this be enough? Vaccine composition –Strains will be identified at VRBPAC* meeting in February –Likely include 2009 H1N1 strain *Vaccines and Related Biological Products Advisory Committee

Thank You!! Questions??